Fenclofenac

Summary

Fenclofenac (CHEMBL15677) is an approved small molecule.

At a glance

• Status: Approved (max clinical phase 4)
• Modality: Small molecule
• Chemistry: 297.1 Da · C14H10Cl2O3

Identifiers

Drug identity and classification

Field	Value
ChEMBL ID	CHEMBL15677
Name	Fenclofenac
Type	Small molecule
Max phase	4
FDA approved	no
PubChem CID	65394
Molecular formula	C14H10Cl2O3
Molecular weight	297.1
InChIKey	IDKAXRLETRCXKS-UHFFFAOYSA-N

SMILES: C1=CC=C(C(=C1)CC(=O)O)OC2=C(C=C(C=C2)Cl)Cl

IUPAC name: 2-[2-(2,4-dichlorophenoxy)phenyl]acetic acid

Also known as: Fenclofenac, Fenclofenaco, R 67408, R-67408, RX 67408, RX-67408, FENCLOFENAC, SID144206863, fenclofenac

Patent coverage: 3,346 distinct patent families (13,345 SureChEMBL compound mentions), from 3 matched compound structure(s). One matched structure accounts for 13,342 (100%) of the total. Mentions count patents naming the compound (not distinct inventions), so promiscuous / reference molecules inflate the mention figure — families are the dedup metric.

Targets

Targets

Broader ChEMBL bioactivity targets: 1 (assay-derived). Sample: Muscarinic acetylcholine receptor M1.

Bioactivity

No ChEMBL bioactivity rows at pChembl ≥ 5 (expected for biologics / antibodies).

Target pathways

No target-pathway data for this drug (no mapped target genes).

Indications & clinical

Indications

0 indication records carry no mapped disease name (EFO/MeSH-only); none shown.

Clinical trials

Total trials: 0.

Clinical evidence (CIViC)

No CIViC predictive evidence (expected for non-precision-medicine drugs).

Pharmacology

Pharmacogenomics

No PharmGKB pharmacogenomic data curated for this drug.

Related molecules

Related molecules

No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).